Loading...
News-22019-10-17T16:01:42-07:00

Evaheart Launches EVA-Pulsar™, Second Generation Destination Therapy Left Ventricular Assist Device (LVAD) Treating Heart Failure Patients

March 4th, 2024|

RareStone’s pitolisant (Wakix) was approved by China NMPA for the treatment of narcolepsy, and became the first approved innovative drug for narcolepsy and the only non-scheduled drug with narcolepsy indication

July 4th, 2023|
Go to Top